Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2021-04-29 Interim / Quarterly Rep…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
ResMed Announces Results for the Third Quarter of FY2021 10 pages 360.8KB
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of financial results for the third quarter of fiscal year 2021 by ResMed Inc. It includes comprehensive financial data such as revenue, gross margin, net income, earnings per share, and detailed financial statements including condensed consolidated statements of operations and balance sheets. The document also discusses operational highlights, tax reserves, dividend declarations, and webcast details for an earnings call. The presence of unaudited financial statements and detailed quarterly financial metrics indicates this is a quarterly financial report rather than a brief earnings release or a simple announcement. The length of the document (15,000 characters) and the inclusion of substantive financial data confirm it is a full interim/quarterly report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2021
2021-04-29 English
Dividend/Distribution - RMD 4 pages 25.5KB
Notice of Dividend Amount Classification · 100% confidence The document is a detailed announcement regarding a dividend distribution by ResMed Inc. It includes specific information such as the dividend amount, ex-date, record date, payment date, currency, withholding tax rate, and other dividend-related details. The content is focused solely on the dividend notification and payment details, without any financial statements or broader financial performance data. The document length is 4661 characters, which is sufficient to contain substantive dividend information. Therefore, this document fits the category of a Notice of Dividend Amount (DIV).
2021-04-29 English
RMD to Report Third Quarter Fiscal 2021 Results 1 p
Regulatory Filings Classification · 95% confidence The document is a press release announcing the date and details of an upcoming earnings report for the third quarter of fiscal 2021. It includes information about the webcast and replay but does not contain any actual financial results or detailed financial data. The document is short (2114 characters) and serves as an announcement rather than the earnings release itself. According to the rules, such announcements about upcoming earnings reports are classified as Earnings Release (ER) announcements only if they contain key highlights, which this document does not. It is primarily an announcement of the earnings report date and webcast details, so it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2021-04-08 English
Chess Depositary Interest - RMD 3 pages 22.2KB
Regulatory Filings Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and provides detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes data for a specific month (March 2021) and explains changes in securities due to transfers and new issuances related to stock options and employee plans. The document is a formal announcement of the current securities on issue rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about securities issued and changes in share capital but does not fit into more specific categories like Share Issue/Capital Change (SHA) since it is primarily a statement of securities on issue rather than a new issuance announcement.
2021-04-06 English
Form 10-K/A - Amendment No. 1 4 pages 134.4KB
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 10-K/A' which indicates it is an amendment to an Annual Report (Form 10-K). It specifically states it is an Amendment No. 1 to the Annual Report for the fiscal year ended June 30, 2020. The text mentions that this amendment is filed solely to include the Auditor Consent that was omitted in the original filing and includes certifications by the CEO and CFO. It explicitly states no financial statements are included in this amendment and no other changes to the original 10-K are made. Since this document is an amendment to the Annual Report and contains regulatory certifications and auditor consent but no substantive financial data or full report content, it is best classified as a Regulatory Filing (RNS) rather than the full Annual Report (10-K). The document length is 7249 characters, which is relatively short and consistent with an amendment filing rather than a full report. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2021-03-30 English
Chess Depositary Interest - RMD 3 pages 22.1KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and contains detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for February 2021, changes in securities, and reasons for those changes such as transfers and new shares issued under employee plans. The document is a formal announcement of the current securities on issue rather than a financial report, earnings release, or management discussion. It does not contain financial statements or management commentary. This type of document fits the category of a Major Shareholding Notification or similar, but since it specifically details securities on issue and changes in share capital, it aligns best with Share Issue/Capital Change (SHA). The document length is under 5,000 characters and is a direct statement rather than a report publication announcement or regulatory filing. Therefore, the classification is SHA with high confidence.
2021-03-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.